Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | F3 | P13726 | 5/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12431618 | 0.89 | HSP90AB1 (0.45) | HSP90AB1SMN1; SMN2F3F2KDM4E | |
| SCHEMBL3556234 | 0.83 | HSP90AB1 (0.54) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL3556233 | 0.83 | HSP90AB1 (0.54) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| Hydrochloric Acid SCHEMBL27715985 | 0.82 | HSP90AB1 (0.53) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL27263584 | 0.76 | HSP90AB1 (0.53) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL12431147 | 0.76 | HSP90AB1 (0.53) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL3561945 | 0.74 | HSP90AB1 (0.65) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL3561942 | 0.74 | HSP90AB1 (0.65) | HSP90AB1SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL13437147 | 0.74 | HSP90AB1 (0.63) | HSP90AB1SMN1; SMN2F3KDM4ERAB9A | |
| SCHEMBL13437177 | 0.74 | HSP90AB1 (0.68) | HSP90AB1SMN1; SMN2F3F2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1888579-B1 | NOVEL FLUORENE DERIVATIVES, COMPOSITION CONTAINING SAID DERIVATIVES AND THE USE THEREOF | AVENTIS PHARMA SA (FR) | 2011-08-03 | — | — | EP | disclosed |
| US-7674795-B2 | Fluorene derivatives, composition containing said derivatives and the use thereof | AVENTIS PHARMA SA (FR) | 2010-03-09 | — | — | US | disclosed |
| US-7674795-B2 | Fluorene derivatives, composition containing said derivatives and the use thereof | AVENTIS PHARMA SA (FR) | 2010-03-09 | — | — | US | disclosed |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | AVENTIS PHARMA S.A. (FR) | 2008-06-26 | — | — | US | disclosed |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | AVENTIS PHARMA S.A. (FR) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | HSP90B1, HSP90AB1, HSP90AA1 | HSP90AB1 2/4885SMN1; SMN2 1564/4885KCNA5 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.